GLABF launches private placement to sell shares, targeting $500K to $1.5M for debt repayment and benchmarking.
Gemina Laboratories (GLABF) announced a non-brokered private placement to raise between $500K and $1.5M by issuing common shares at $0.03 each. The proceeds will be used to repay debt and fund benchmarking activities.
The company did not disclose prior fundraising rounds or consensus expectations for this placement. No immediate market reaction was reported following the announcement.
Shares are priced at $0.03, reflecting the company’s current valuation and capital needs.